MPM BioImpact

Established in 2011, MPM BioImpact is a Massachusetts-based long/short equity hedge fund manager that focuses on health care. It was originally founded as Burrage Capital until July 2021, when it finalized a merger with MPM Capital and changed the name. It uses in-depth medical and industry research to identify undervalued companies that are developing compelling drugs, medical technologies, research tools, and diagnostics. The investment process at the firm is driven by deep industry research and insight. The first step is the identification of quality scientific and clinical assets. The next steps include diligence through an established network of medical, regulatory, and commercial industry leaders. Investments are then made opportunistically when there is a compelling risk/reward. The firm's investments are run by management teams with scientific, clinical, regulatory, and financial experience.